SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Circle Internet Group, Inc. is a financial technology company that enables businesses of all sizes to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide. The company was founded by Jeremy J. Allaire and Patrick Sean Neville in August 2013 and is headquartered in New York, NY.

Circle Internet Group Inc. - Ordinary Shares - Class A

Circle

Circle shares fell after the U.S. Senate failed to advance the CLARITY Act, a bill intended to establish a comprehensive regulatory framework for digital assets. The legislative setback, coupled with broader market uncertainty and profit-taking after recent gains, has driven the stock lower as investors weigh the loss of immediate regulatory clarity.

Wingstop, Inc. is a franchisor and chicken wings-focused restaurant. The firm is engaged in the flavor business offering cooked-to-order, hand-sauced, and tossed classic and boneless wings, tenders and chicken sandwiches in flavors, with signature sides, such as its seasoned fries and house made ranch and bleu cheese dips. The company was founded in 1994 and is headquartered in Dallas, TX.

Wingstop Inc

Wingstop shares are trending downward amid a broader selloff in restaurant stocks, driven by industry-wide reports of declining foot traffic and consumer spending pressures. Traders are divided between those attempting to buy the dip based on long-term growth and those anticipating further downside due to inflation and competitive concerns.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius Holdings is trending as the community debates the significance of recent insider purchases, including a notable $1 million acquisition by a director and additional buying by the CEO. While many traders interpret these moves as high-conviction signals that the stock has bottomed, skeptics dismiss the purchases as optics or insufficient to address ongoing challenges with the core brand's growth and management's performance.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase shares and the broader crypto sector declined following the U.S. Senate's failure to advance the CLARITY Act, a regulatory framework for digital assets that had been a focal point of market optimism. Traders expressed frustration over the legislative deadlock and persistent regulatory uncertainty, with many pointing to a 'sell the news' reaction and broader economic concerns as key drivers for the downward price action.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending as traders speculate on the timing and results of the maintenance data for VK2735, with many investors debating the effectiveness of CEO Brian Lian's communication style ahead of upcoming investor conferences. While some community members express frustration over the stock's recent volatility and lack of a partnership announcement, others maintain a bullish conviction that the underlying science will ultimately drive significant long-term value.

Forgent Power Solutions, Inc. is a holding company, which engages in the design and manufacture of electrical distribution equipment used in data centers, power grid, and energy-intensive industrial facilities. It also offers powertrain solutions and standard and custom products. The company was founded on July 21, 2025 and is headquartered in Dayton, MN.

Forgent Power Solutions Inc. - Ordinary Shares - Class A

Forgent Power Solutions Inc.

Forgent Power Solutions is trending due to record fiscal fourth-quarter results, highlighted by strong revenue growth and a record backlog that exceeded annual revenue, alongside bullish fiscal 2027 guidance and a capacity-expanding manufacturing investment. While sentiment is extremely bullish, some market participants remain cautious, noting that the stock has historically been sensitive to equity offerings and potential institutional selling overhang.

Dutch Bros, Inc. engages in operating and franchising drive-thru shops that focus on handcrafted beverages. It operates through the Company-Operated Shops, and Franchising and Other segments. The Company-Operated Shops segment consists of coffee shop sales to customers. The Franchising and Other segment is involved in bean and product sales to franchisees and includes the initial franchise fees, royalties, and marketing fees. The company was founded by Travis Boersma and Dane Boersma in 1992 and is headquartered in Tempe, AZ.

Dutch Bros Inc - Ordinary Shares - Class A

Dutch Bros Inc

Dutch Bros shares are experiencing significant selling pressure following the latest quarterly report, as investors reacted to conservative third-quarter guidance and concerns over high valuation despite a revenue beat. The community remains divided, with many traders viewing the current pullback as a buying opportunity given the company's aggressive expansion plans, while others argue the stock remains overvalued and vulnerable to further downside.

Western Digital Corp. engages in the development, manufacture, marketing, and sale of data storage devices and solutions. It operates through the Hard Disk Drives (HDD) segment. The company was founded by Alvin B. Phillips in 1970 and is headquartered in San Jose, CA.

Western Digital Corp.

Western Digital is experiencing significant volatility and price weakness as investors rotate out of the memory sector, despite reported earnings growth and strong demand for AI-related data infrastructure. While some traders view the pullback as a buying opportunity given the company's role in the AI storage supply chain, others are expressing concern over potential market manipulation, the broader cyclicality of the memory industry, and cooling sector sentiment.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

Tempus AI Inc

Tempus AI shares surged following positive Phase 3 clinical trial results from Moderna and Merck involving their personalized mRNA cancer vaccine, which validates the technology behind the company's pending acquisition of Personalis. Community discussion heavily focuses on the stock's potential for a short squeeze given high short interest, though some traders remain skeptical of its fundamental valuation and long-term profitability.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. It will generate domestically produced bitcoin powered by nuclear, hydro, and solar energy. It operates through the Digital Asset Mining and HPC Leasing segments. The company was founded by Paul B. Prager and Nazar M. Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

TeraWulf is currently experiencing significant volatility and downward pressure, with investors heavily debating its long-term potential as an AI infrastructure and data center play against short-term concerns regarding high short interest, insider selling, and macroeconomic factors. While bulls emphasize the massive revenue potential from long-term contracts and institutional backing, bears express frustration over the stock's poor price performance and persistent losses, leading to intense sentiment clashes across the community.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Can Adherex Technologies (FENC) Climb 26.53% to Reach the Level Wall Street Analysts Expect?

The mean of analysts' price targets for Adherex Technologies (FENC) points to a 26.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Adherex Technologies Inc. (FENC) Beats Q2 Earnings and Revenue Estimates

Adherex Technologies (FENC) delivered earnings and revenue surprises of +400.00% and +11.73%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Septerna, Inc. (SEPN) Reports Q2 Loss, Beats Revenue Estimates

Septerna, Inc. (SEPN) delivered earnings and revenue surprises of +39.58% and +30.07%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Is the Options Market Predicting a Spike in Adherex Technologies Stock?

Investors need to pay close attention to FENC stock based on the movements in the options market lately.

Do Options Traders Know Something About Adherex Technologies Stock We Don't?

Investors need to pay close attention to FENC stock based on the movements in the options market lately. 

Adherex Technologies Inc. (FENC) Beats Q1 Earnings and Revenue Estimates

Adherex Technologies (FENC) delivered earnings and revenue surprises of +157.14% and +8.36%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

MaxCyte, Inc. (MXCT) Reports Q1 Loss, Tops Revenue Estimates

MaxCyte (MXCT) delivered earnings and revenue surprises of +57.90% and +31.31%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Iovance Biotherapeutics (IOVA) Reports Q1 Loss, Lags Revenue Estimates

Iovance Biotherapeutics (IOVA) delivered earnings and revenue surprises of 0.00% and -7.36%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Adherex Technologies (FENC) Expected to Announce Quarterly Earnings on Tuesday

Adherex Technologies (NASDAQ:FENC) will be releasing its Q1 2026 earnings before the market opens on Tuesday, May 12. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-12-fennec-pharmaceuticals-inc-stock...

Insider Selling: Adherex Technologies (NASDAQ:FENC) Director Sells 10,781 Shares of Stock

Adherex Technologies Inc. (NASDAQ:FENC - Get Free Report) Director Rosty Raykov sold 10,781 shares of the business's stock in a transaction that occurred on Friday, May 1st. The stock was sold at an average price of $6.47, for a total value of $69,753.07. Following the sale, the director owned...

Fennec Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses on the development and commercialization of PEDMARK to reduce the risk of platinum-induced ototoxicity in pediatric patients. The company was founded by Orest W. Blaschuk on September 3, 1996 and is headquartered in Durham, NC.

Fennec Pharmaceuticals Inc

Neutral Sentiment

50bps hike

25bps hike

No change

25bps cut

The Federal Reserve's September FOMC meeting concludes Wednesday, September 16, with a rate decision due at 2:00 PM ET, following Tuesday's CPI report that showed inflation still running above the Fed's 2% target. What do you think the Fed decides at this week's FOMC meeting? Vote and explain your reasoning in the comments.

The Fed&#39;s rate decision comes Wednesday at 2PM ET. What do you think happens?

Stocktwits

The Fed's rate decision comes Wednesday at 2PM ET. What do you think happens?

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '26	$0.09	--	--	N/A
Q2 '26	$0.02	$0.05	150.00%	BEAT
Q1 '26	-$0.04	$0.01	122.81%	BEAT
Q4 '25	$0.04	-$0.17	-503.03%	MISSED
Q3 '25	-$0.02	-$0.02	9.09%	BEAT

Feed

News

Sentiment

Earnings

Fundamentals

Info

FENC Earnings

Upcoming Earnings: Q3 '26

Historical Earnings